Dr. Roger Klein Discusses the Latest Spike in Omicron Cases

Roger D Klein, MD, JD is an expert with the Regulatory Transparency Project’s FDA and Health Working Group. Former Director of Molecular Oncology at the Cleveland Clinic, former advisor to the FDA, CDC, CMS, and HHS

TAGGED:
Share This Article